<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38593796</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4180</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>14</Day></PubDate></JournalIssue><Title>Immunity</Title><ISOAbbreviation>Immunity</ISOAbbreviation></Journal><ArticleTitle>Type I interferons induce an epigenetically distinct memory B cell subset in chronic viral infection.</ArticleTitle><Pagination><StartPage>1037</StartPage><EndPage>1055.e6</EndPage><MedlinePgn>1037-1055.e6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.immuni.2024.03.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1074-7613(24)00137-7</ELocationID><Abstract><AbstractText>Memory B cells (MBCs) are key providers of long-lived immunity against infectious disease, yet in chronic viral infection, they do not produce effective protection. How chronic viral infection disrupts MBC development and whether such changes are reversible remain unknown. Through single-cell (sc)ATAC-seq and scRNA-seq during acute versus chronic lymphocytic choriomeningitis viral infection, we identified a memory subset enriched for interferon (IFN)-stimulated genes (ISGs) during chronic infection that was distinct from the T-bet<sup>+</sup> subset normally associated with chronic infection. Blockade of IFNAR-1 early in infection transformed the chromatin landscape of chronic MBCs, decreasing accessibility at ISG-inducing transcription factor binding motifs and inducing phenotypic changes in the dominating MBC subset, with a decrease in the ISG subset and an increase in CD11c<sup>+</sup>CD80<sup>+</sup> cells. However, timing was critical, with MBCs resistant to intervention at 4&#xa0;weeks post-infection. Together, our research identifies a key mechanism to instruct MBC identity during viral infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polmear</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kealy</LastName><ForeName>Liam</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szeto</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Ee Shan</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Mansi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirn</LastName><ForeName>Alana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Justin J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Katherine J L</ForeName><Initials>KJL</Initials><AffiliationInfo><Affiliation>Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broomfield</LastName><ForeName>Benjamin J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia; Division of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gago da Gra&#xe7;a</LastName><ForeName>Catarina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Gruta</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Utzschneider</LastName><ForeName>Daniel T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groom</LastName><ForeName>Joanna R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Division of Immunology, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martelotto</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Adelaide Centre for Epigenetics and the South Australian Immunogenomics Cancer Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; University of Melbourne Centre for Cancer Research, Victoria Comprehensive Cancer Centre, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parish</LastName><ForeName>Ian A</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia; John Curtin School of Medical Research, ANU, Canberra, ACT, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Keeffe</LastName><ForeName>Meredith</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scharer</LastName><ForeName>Christopher D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gras</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Good-Jacobson</LastName><ForeName>Kim L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia; Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia. Electronic address: kim.jacobson@monash.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI148471</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Immunity</MedlineTA><NlmUniqueID>9432918</NlmUniqueID><ISSNLinking>1074-7613</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="Y">Interferon Type I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008216" MajorTopicYN="Y">Lymphocytic Choriomeningitis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008217" MajorTopicYN="Y">Lymphocytic choriomeningitis virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000091245" MajorTopicYN="Y">Memory B Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053633" MajorTopicYN="N">Receptor, Interferon alpha-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007156" MajorTopicYN="N">Immunologic Memory</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016175" MajorTopicYN="N">B-Lymphocyte Subsets</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059010" MajorTopicYN="N">Single-Cell Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B cells</Keyword><Keyword MajorTopicYN="N">IFN</Keyword><Keyword MajorTopicYN="N">LCMV</Keyword><Keyword MajorTopicYN="N">atypical</Keyword><Keyword MajorTopicYN="N">chronic viral infection</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">memory B cells</Keyword><Keyword MajorTopicYN="N">scATAC-seq</Keyword><Keyword MajorTopicYN="N">scRNA-seq</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>9</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38593796</ArticleId><ArticleId IdType="mid">NIHMS1980180</ArticleId><ArticleId IdType="pmc">PMC11096045</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2024.03.016</ArticleId><ArticleId IdType="pii">S1074-7613(24)00137-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maruyama M, Lam KP, and Rajewsky K (2000). Memory B-cell persistence is independent of persisting immunizing antigen.[see comment][erratum appears in Nature 2001 Jan 18;409(6818):382]. Nature 407, 636&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">11034213</ArticleId></ArticleIdList></Reference><Reference><Citation>Schittek B, and Rajewsky K (1990). Maintenance of B-cell memory by long-lived cells generated from proliferating precursors. Nature 346, 749&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pubmed">2388695</ArticleId></ArticleIdList></Reference><Reference><Citation>Good KL, and Tangye SG (2007). Decreased expression of Kruppel-like factors in memory B cells induces the rapid response typical of secondary antibody responses. Proc Natl Acad Sci U S A 104, 13420&#x2013;13425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1948953</ArticleId><ArticleId IdType="pubmed">17673551</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro A, Polmear J, Cooper L, Damelang T, Hussain T, Hailes L, O&#x2019;Donnell K, Udupa V, Mi T, Preston S, et al. (2022). Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection. Nat Immunol 23, 86&#x2013;98. 10.1038/s41590-021-01077-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01077-y</ArticleId><ArticleId IdType="pubmed">34845392</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper L, and Good-Jacobson KL (2020). Dysregulation of humoral immunity in chronic infection. Immunol Cell Biol 98, 456&#x2013;466. 10.1111/imcb.12338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imcb.12338</ArticleId><ArticleId IdType="pubmed">32275789</ArticleId></ArticleIdList></Reference><Reference><Citation>Park A, and Iwasaki A (2020). Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19. Cell Host Microbe 27, 870&#x2013;878. 10.1016/j.chom.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7255347</ArticleId><ArticleId IdType="pubmed">32464097</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F, Mayer-Barber K, Sher A, Wack A, and O&#x2019;Garra A (2015). Type I interferons in infectious disease. Nat Rev Immunol 15, 87&#x2013;103. 10.1038/nri3787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, et al. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol 23, 210&#x2013;216. 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Holla P, Dizon B, Ambegaonkar AA, Rogel N, Goldschmidt E, Boddapati AK, Sohn H, Sturdevant D, Austin JW, Kardava L, et al. (2021). Shared transcriptional profiles of atypical B cells suggest common drivers of expansion and function in malaria, HIV, and autoimmunity. Sci Adv 7. 10.1126/sciadv.abg8384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg8384</ArticleId><ArticleId IdType="pmc">PMC8153733</ArticleId><ArticleId IdType="pubmed">34039612</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldstone MB (2015). A Jekyll and Hyde Profile: Type 1 Interferon Signaling Plays a Prominent Role in the Initiation and Maintenance of a Persistent Virus Infection. J Infect Dis 212 Suppl 1, S31&#x2013;36. 10.1093/infdis/jiu501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu501</ArticleId><ArticleId IdType="pmc">PMC4574552</ArticleId><ArticleId IdType="pubmed">26116728</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldstone MBA, Ware BC, Horton LE, Welch MJ, Aiolfi R, Zarpellon A, Ruggeri ZM, and Sullivan BM (2018). Lymphocytic choriomeningitis virus Clone 13 infection causes either persistence or acute death dependent on IFN-1, cytotoxic T lymphocytes (CTLs), and host genetics. Proc Natl Acad Sci U S A 115, E7814&#x2013;E7823. 10.1073/pnas.1804674115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1804674115</ArticleId><ArticleId IdType="pmc">PMC6099862</ArticleId><ArticleId IdType="pubmed">30061383</ArticleId></ArticleIdList></Reference><Reference><Citation>Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O&#x2019;Shea MA, Roby G, Kottilil S, Arthos J, Proschan MA, et al. (2008). Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med 205, 1797&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2525604</ArticleId><ArticleId IdType="pubmed">18625747</ArticleId></ArticleIdList></Reference><Reference><Citation>Kealy L, and Good-Jacobson KL (2021). Advances in understanding the formation and fate of B-cell memory in response to immunisation or infection. Oxford Open Immunology 2, iqab018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8499879</ArticleId><ArticleId IdType="pubmed">36845573</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, Tabachnikova A, Tabacof L, Malik AA, Kamath K, et al. (2022). Distinguishing features of Long COVID identified through immune profiling. medRxiv. 10.1101/2022.08.09.22278592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JL, Rosenthal RL, Knox JJ, Myles A, Naradikian MS, Madej J, Kostiv M, Rosenfeld AM, Meng W, Christensen SR, et al. (2020). The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans. Immunity 52, 842&#x2013;855 e846. 10.1016/j.immuni.2020.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.03.020</ArticleId><ArticleId IdType="pmc">PMC7242168</ArticleId><ArticleId IdType="pubmed">32353250</ArticleId></ArticleIdList></Reference><Reference><Citation>Allie SR, Bradley JE, Mudunuru U, Schultz MD, Graf BA, Lund FE, and Randall TD (2019). The establishment of resident memory B cells in the lung requires local antigen encounter. Nat Immunol 20, 97&#x2013;108. 10.1038/s41590-018-0260-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0260-6</ArticleId><ArticleId IdType="pmc">PMC6392030</ArticleId><ArticleId IdType="pubmed">30510223</ArticleId></ArticleIdList></Reference><Reference><Citation>Piovesan D, Tempany J, Di Pietro A, Baas I, Yiannis C, O&#x2019;Donnell K, Chen Y, Peperzak V, Belz GT, Mackay CR, et al. (2017). c-Myb Regulates the T-Bet-Dependent Differentiation Program in B Cells to Coordinate Antibody Responses. Cell Rep 19, 461&#x2013;470. 10.1016/j.celrep.2017.03.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.03.060</ArticleId><ArticleId IdType="pubmed">28423310</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Avery DT, Jackson KJL, Ogishi M, Benhsaien I, Du L, Ye X, Han J, Rosain J, Peel JN, et al. (2022). Human T-bet governs the generation of a distinct subset of CD11c(high)CD21(low) B cells. Sci Immunol 7, eabq3277. 10.1126/sciimmunol.abq3277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abq3277</ArticleId><ArticleId IdType="pmc">PMC9413977</ArticleId><ArticleId IdType="pubmed">35867801</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, Antao OQ, Condiff E, Sanchez GM, Chernova I, Zembrzuski K, Steach H, Rubtsova K, Angeletti D, Lemenze A, et al. (2022). Development of Tbet- and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers. Immunity 55, 290&#x2013;307 e295. 10.1016/j.immuni.2022.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.002</ArticleId><ArticleId IdType="pmc">PMC8965751</ArticleId><ArticleId IdType="pubmed">35090581</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton HJ, Aye R, Idris AH, Vistein R, Nduati E, Kai O, Mwacharo J, Li X, Gao X, Andrews TD, et al. (2021). Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans. Cell Rep 34, 108684. 10.1016/j.celrep.2020.108684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108684</ArticleId><ArticleId IdType="pmc">PMC7873835</ArticleId><ArticleId IdType="pubmed">33567273</ArticleId></ArticleIdList></Reference><Reference><Citation>Molinos-Albert LM, Lorin V, Monceaux V, Orr S, Essat A, Dufloo J, Schwartz O, Rouzioux C, Meyer L, Hocqueloux L, et al. (2022). Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers. Nat Commun 13, 1944. 10.1038/s41467-022-29511-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29511-1</ArticleId><ArticleId IdType="pmc">PMC9001681</ArticleId><ArticleId IdType="pubmed">35410989</ArticleId></ArticleIdList></Reference><Reference><Citation>Moir S, and Fauci AS (2009). B cells in HIV infection and disease. Nat Rev Immunol 9, 235&#x2013;245. 10.1038/nri2524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2524</ArticleId><ArticleId IdType="pmc">PMC2779527</ArticleId><ArticleId IdType="pubmed">19319142</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro A, and Good-Jacobson KL (2018). Disrupting the Code: Epigenetic Dysregulation of Lymphocyte Function during Infectious Disease and Lymphoma Development. J Immunol 201, 1109&#x2013;1118. 10.4049/jimmunol.1800137.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1800137</ArticleId><ArticleId IdType="pubmed">30082273</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, and Good-Jacobson KL (2019). Epigenetic regulation of B cell fate and function during an immune response. Immunol Rev 288, 75&#x2013;84. 10.1111/imr.12733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12733</ArticleId><ArticleId IdType="pubmed">30874352</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen DR, Kaminski J, Barnitz RA, Kurachi M, Gerdemann U, Yates KB, Tsao HW, Godec J, LaFleur MW, Brown FD, et al. (2016). The epigenetic landscape of T cell exhaustion. Science 354, 1165&#x2013;1169. 10.1126/science.aae0491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aae0491</ArticleId><ArticleId IdType="pmc">PMC5497589</ArticleId><ArticleId IdType="pubmed">27789799</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauken KE, Sammons MA, Odorizzi PM, Manne S, Godec J, Khan O, Drake AM, Chen Z, Sen DR, Kurachi M, et al. (2016). Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science 354, 1160&#x2013;1165. 10.1126/science.aaf2807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf2807</ArticleId><ArticleId IdType="pmc">PMC5484795</ArticleId><ArticleId IdType="pubmed">27789795</ArticleId></ArticleIdList></Reference><Reference><Citation>Yates KB, Tonnerre P, Martin GE, Gerdemann U, Al Abosy R, Comstock DE, Weiss SA, Wolski D, Tully DC, Chung RT, et al. (2021). Epigenetic scars of CD8(+) T cell exhaustion persist after cure of chronic infection in humans. Nat Immunol 22, 1020&#x2013;1029. 10.1038/s41590-021-00979-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00979-1</ArticleId><ArticleId IdType="pmc">PMC8600539</ArticleId><ArticleId IdType="pubmed">34312547</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Hakeem MS, Manne S, Beltra JC, Stelekati E, Chen Z, Nzingha K, Ali MA, Johnson JL, Giles JR, Mathew D, et al. (2021). Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation. Nat Immunol 22, 1008&#x2013;1019. 10.1038/s41590-021-00975-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00975-5</ArticleId><ArticleId IdType="pmc">PMC8323971</ArticleId><ArticleId IdType="pubmed">34312545</ArticleId></ArticleIdList></Reference><Reference><Citation>Harker JA, Lewis GM, Mack L, and Zuniga EI (2011). Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 334, 825&#x2013;829. 10.1126/science.1208421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1208421</ArticleId><ArticleId IdType="pmc">PMC3388900</ArticleId><ArticleId IdType="pubmed">21960530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Ou R, Huang L, Price GE, and Moskophidis D (2004). Differential tissue-specific regulation of antiviral CD8+ T-cell immune responses during chronic viral infection. J Virol 78, 3578&#x2013;3600. 10.1128/jvi.78.7.3578-3600.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.78.7.3578-3600.2004</ArticleId><ArticleId IdType="pmc">PMC371037</ArticleId><ArticleId IdType="pubmed">15016881</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinkernagel RM, Haenseler E, Leist T, Cerny A, Hengartner H, and Althage A (1986). T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? J Exp Med 164, 1075&#x2013;1092. 10.1084/jem.164.4.1075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.164.4.1075</ArticleId><ArticleId IdType="pmc">PMC2188412</ArticleId><ArticleId IdType="pubmed">3489805</ArticleId></ArticleIdList></Reference><Reference><Citation>Holla P, Ambegaonkar A, Sohn H, and Pierce SK (2019). Exhaustion may not be in the human B cell vocabulary, at least not in malaria. Immunol Rev 292, 139&#x2013;148. 10.1111/imr.12809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12809</ArticleId><ArticleId IdType="pubmed">31553065</ArticleId></ArticleIdList></Reference><Reference><Citation>Moseman EA, Wu T, de la Torre JC, Schwartzberg PL, and McGavern DB (2016). Type I interferon suppresses virus-specific B cell responses by modulating CD8+ T cell differentiation. Sci Immunol 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089817</ArticleId><ArticleId IdType="pubmed">27812556</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallet B, Narr K, Ertuna YI, Remy M, Sommerstein R, Cornille K, Kreutzfeldt M, Page N, Zimmer G, Geier F, et al. (2016). Interferon-driven deletion of antiviral B cells at the onset of chronic infection. Sci Immunol 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5115616</ArticleId><ArticleId IdType="pubmed">27872905</ArticleId></ArticleIdList></Reference><Reference><Citation>Sammicheli S, Kuka M, Di Lucia P, de Oya NJ, De Giovanni M, Fioravanti J, Cristofani C, Maganuco CG, Fallet B, Ganzer L, et al. (2016). Inflammatory monocytes hinder antiviral B cell responses. Sci Immunol 1. 10.1126/sciimmunol.aah6789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aah6789</ArticleId><ArticleId IdType="pmc">PMC5111729</ArticleId><ArticleId IdType="pubmed">27868108</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldstone MB, and Buchmeier MJ (1982). Restricted expression of viral glycoprotein in cells of persistently infected mice. Nature 300, 360&#x2013;362. 10.1038/300360a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/300360a0</ArticleId><ArticleId IdType="pubmed">7144891</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JJ, Martinez RJ, Titcombe PJ, Barsness LO, Thomas SR, Zhang N, Katzman SD, Jenkins MK, and Mueller DL (2012). Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen. J Exp Med 209, 2065&#x2013;2077. 10.1084/jem.20112272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20112272</ArticleId><ArticleId IdType="pmc">PMC3478923</ArticleId><ArticleId IdType="pubmed">23071255</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallet B, Hao Y, Florova M, Cornille K, de Los Aires AV, Girelli Zubani G, Ertuna YI, Greiff V, Menzel U, Hammad K, et al. (2020). Chronic Viral Infection Promotes Efficient Germinal Center B Cell Responses. Cell Rep 30, 1013&#x2013;1026 e1017. 10.1016/j.celrep.2019.12.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.12.023</ArticleId><ArticleId IdType="pmc">PMC6996002</ArticleId><ArticleId IdType="pubmed">31995746</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaros V, Rauschmeier R, Artemov AV, Reinhardt A, Ols S, Emmanouilidi A, Gustafsson C, You Y, Mirabello C, Bjorklund AK, et al. (2021). Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response. Immunity 54, 2005&#x2013;2023 e2010. 10.1016/j.immuni.2021.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.08.017</ArticleId><ArticleId IdType="pmc">PMC7612941</ArticleId><ArticleId IdType="pubmed">34525339</ArticleId></ArticleIdList></Reference><Reference><Citation>Good KL, Avery DT, and Tangye SG (2009). Resting human memory B cells are intrinsically programmed for enhanced survival and responsiveness to diverse stimuli compared to naive B cells. J Immunol 182, 890&#x2013;901.</Citation><ArticleIdList><ArticleId IdType="pubmed">19124732</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuccarino-Catania GV, Sadanand S, Weisel FJ, Tomayko MM, Meng H, Kleinstein SH, Good-Jacobson KL, and Shlomchik MJ (2014). CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. Nat Immunol 15, 631&#x2013;637. 10.1038/ni.2914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2914</ArticleId><ArticleId IdType="pmc">PMC4105703</ArticleId><ArticleId IdType="pubmed">24880458</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape KA, Taylor JJ, Maul RW, Gearhart PJ, and Jenkins MK (2011). Different B cell populations mediate early and late memory during an endogenous immune response. Science 331, 1203&#x2013;1207. science.1201730 [pii] 10.1126/science.1201730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1201730</ArticleId><ArticleId IdType="pmc">PMC3993090</ArticleId><ArticleId IdType="pubmed">21310965</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogan I, Bertocci B, Vilmont V, Delbos F, Megret J, Storck S, Reynaud CA, and Weill JC (2009). Multiple layers of B cell memory with different effector functions. Nat Immunol 10, 1292&#x2013;1299.</Citation><ArticleIdList><ArticleId IdType="pubmed">19855380</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomayko MM, Steinel NC, Anderson SM, and Shlomchik MJ (2010). Cutting edge: Hierarchy of maturity of murine memory B cell subsets. J Immunol 185, 7146&#x2013;7150. jimmunol.1002163 [pii] 10.4049/jimmunol.1002163.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002163</ArticleId><ArticleId IdType="pmc">PMC3133669</ArticleId><ArticleId IdType="pubmed">21078902</ArticleId></ArticleIdList></Reference><Reference><Citation>Viant C, Wirthmiller T, ElTanbouly MA, Chen ST, Cipolla M, Ramos V, Oliveira TY, Stamatatos L, and Nussenzweig MC (2021). Germinal center-dependent and -independent memory B cells produced throughout the immune response. J Exp Med 218. 10.1084/jem.20202489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202489</ArticleId><ArticleId IdType="pmc">PMC8193567</ArticleId><ArticleId IdType="pubmed">34106207</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue T, Shinnakasu R, Kawai C, Ise W, Kawakami E, Sax N, Oki T, Kitamura T, Yamashita K, Fukuyama H, and Kurosaki T (2021). Exit from germinal center to become quiescent memory B cells depends on metabolic reprograming and provision of a survival signal. J Exp Med 218. 10.1084/jem.20200866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20200866</ArticleId><ArticleId IdType="pmc">PMC7555411</ArticleId><ArticleId IdType="pubmed">33045065</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedel R, Addo R, Ferreira-Gomes M, Heinz GA, Heinrich F, Kummer J, Greiff V, Schulz D, Klaeden C, Cornelis R, et al. (2020). Discrete populations of isotype-switched memory B lymphocytes are maintained in murine spleen and bone marrow. Nat Commun 11, 2570. 10.1038/s41467-020-16464-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16464-6</ArticleId><ArticleId IdType="pmc">PMC7244721</ArticleId><ArticleId IdType="pubmed">32444631</ArticleId></ArticleIdList></Reference><Reference><Citation>Laidlaw BJ, Schmidt TH, Green JA, Allen CD, Okada T, and Cyster JG (2017). The Eph-related tyrosine kinase ligand Ephrin-B1 marks germinal center and memory precursor B cells. J Exp Med 214, 639&#x2013;649. 10.1084/jem.20161461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20161461</ArticleId><ArticleId IdType="pmc">PMC5339677</ArticleId><ArticleId IdType="pubmed">28143955</ArticleId></ArticleIdList></Reference><Reference><Citation>Suan D, Krautler NJ, Maag JLV, Butt D, Bourne K, Hermes JR, Avery DT, Young C, Statham A, Elliott M, et al. (2017). CCR6 Defines Memory B Cell Precursors in Mouse and Human Germinal Centers, Revealing Light-Zone Location and Predominant Low Antigen Affinity. Immunity 47, 1142&#x2013;1153 e1144. 10.1016/j.immuni.2017.11.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.11.022</ArticleId><ArticleId IdType="pubmed">29262350</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart GT, Wang X, Hogquist KA, and Jameson SC (2011). Kruppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression. Proc Natl Acad Sci U S A 108, 716&#x2013;721. 10.1073/pnas.1013168108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1013168108</ArticleId><ArticleId IdType="pmc">PMC3021025</ArticleId><ArticleId IdType="pubmed">21187410</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang NS, McHeyzer-Williams LJ, Okitsu SL, Burris TP, Reiner SL, and McHeyzer-Williams MG (2012). Divergent transcriptional programming of class-specific B cell memory by T-bet and RORalpha. Nat Immunol 13, 604&#x2013;611. 10.1038/ni.2294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2294</ArticleId><ArticleId IdType="pmc">PMC3362691</ArticleId><ArticleId IdType="pubmed">22561605</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, Ley AM, Kyu S, Howell JC, Ozturk T, et al. (2020). Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol 21, 1506&#x2013;1516. 10.1038/s41590-020-00814-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00814-z</ArticleId><ArticleId IdType="pmc">PMC7739702</ArticleId><ArticleId IdType="pubmed">33028979</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, and Glass CK (2010). Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38, 576&#x2013;589. 10.1016/j.molcel.2010.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.05.004</ArticleId><ArticleId IdType="pmc">PMC2898526</ArticleId><ArticleId IdType="pubmed">20513432</ArticleId></ArticleIdList></Reference><Reference><Citation>Schep AN, Wu B, Buenrostro JD, and Greenleaf WJ (2017). chromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nat Methods 14, 975&#x2013;978. 10.1038/nmeth.4401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4401</ArticleId><ArticleId IdType="pmc">PMC5623146</ArticleId><ArticleId IdType="pubmed">28825706</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauschmeier R, Reinhardt A, Gustafsson C, Glaros V, Artemov AV, Dunst J, Taneja R, Adameyko I, Mansson R, Busslinger M, and Kreslavsky T (2022). Bhlhe40 function in activated B and TFH cells restrains the GC reaction and prevents lymphomagenesis. J Exp Med 219. 10.1084/jem.20211406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20211406</ArticleId><ArticleId IdType="pmc">PMC8689665</ArticleId><ArticleId IdType="pubmed">34919144</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Ashbrook AW, Du Y, Wu J, Hoffmann HH, Zhang C, Xia L, Peng YC, Tumas KC, Singh BK, et al. (2020). RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology. Proc Natl Acad Sci U S A 117, 19465&#x2013;19474. 10.1073/pnas.2006492117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2006492117</ArticleId><ArticleId IdType="pmc">PMC7431001</ArticleId><ArticleId IdType="pubmed">32709745</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugan M, Murira A, Mindt BC, Germain A, Tarrab E, Lapierre P, Fritz JH, and Lamarre A (2016). Type I Interferon Impairs Specific Antibody Responses Early during Establishment of LCMV Infection. Front Immunol 7, 564. 10.3389/fimmu.2016.00564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00564</ArticleId><ArticleId IdType="pmc">PMC5136549</ArticleId><ArticleId IdType="pubmed">27994594</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang R, Sun L, Li CF, Wang YH, Yao J, Li H, Yan M, Chang WC, Hsu JM, Cha JH, et al. (2021). Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat Commun 12, 832. 10.1038/s41467-021-21099-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21099-2</ArticleId><ArticleId IdType="pmc">PMC7864927</ArticleId><ArticleId IdType="pubmed">33547304</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf Y, Anderson AC, and Kuchroo VK (2020). TIM3 comes of age as an inhibitory receptor. Nat Rev Immunol 20, 173&#x2013;185. 10.1038/s41577-019-0224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0224-6</ArticleId><ArticleId IdType="pmc">PMC7327798</ArticleId><ArticleId IdType="pubmed">31676858</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Swiecki M, Cella M, Alber G, Schreiber RD, Gilfillan S, and Colonna M (2012). Timing and magnitude of type I interferon responses by distinct sensors impact CD8 T cell exhaustion and chronic viral infection. Cell Host Microbe 11, 631&#x2013;642. 10.1016/j.chom.2012.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.05.003</ArticleId><ArticleId IdType="pmc">PMC3572910</ArticleId><ArticleId IdType="pubmed">22704623</ArticleId></ArticleIdList></Reference><Reference><Citation>Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, Schreiber RD, de la Torre JC, and Oldstone MB (2013). Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207&#x2013;211. 10.1126/science.1235214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1235214</ArticleId><ArticleId IdType="pmc">PMC3640797</ArticleId><ArticleId IdType="pubmed">23580529</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, Pere H, Charbit B, Bondet V, Chenevier-Gobeaux C, et al. (2020). Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718&#x2013;724. 10.1126/science.abc6027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Vartak SV, Conte A, Wang X, Garcia DA, Stevens E, Kyoung Jung S, Kieffer-Kwon KR, Vian L, Stodola T, et al. (2022). &#x201c;Stripe&#x201d; transcription factors provide accessibility to co-binding partners in mammalian genomes. Mol Cell 82, 3398&#x2013;3411 e3311. 10.1016/j.molcel.2022.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2022.06.029</ArticleId><ArticleId IdType="pmc">PMC9481673</ArticleId><ArticleId IdType="pubmed">35863348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kardava L, Moir S, Shah N, Wang W, Wilson R, Buckner CM, Santich BH, Kim LJ, Spurlin EE, Nelson AK, et al. (2014). Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals. J Clin Invest 124, 3252&#x2013;3262. 10.1172/jci74351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci74351</ArticleId><ArticleId IdType="pmc">PMC4071400</ArticleId><ArticleId IdType="pubmed">24892810</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisel FJ, Zuccarino-Catania GV, Chikina M, and Shlomchik MJ (2016). A Temporal Switch in the Germinal Center Determines Differential Output of Memory B and Plasma Cells. Immunity 44, 116&#x2013;130. 10.1016/j.immuni.2015.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.12.004</ArticleId><ArticleId IdType="pmc">PMC4724390</ArticleId><ArticleId IdType="pubmed">26795247</ArticleId></ArticleIdList></Reference><Reference><Citation>Good-Jacobson KL (2021). Engraving our first B cell memories into the repertoire. Trends Immunol 42, 951&#x2013;952. 10.1016/j.it.2021.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2021.09.009</ArticleId><ArticleId IdType="pubmed">34635394</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JJ, Pape KA, and Jenkins MK (2012). A germinal center-independent pathway generates unswitched memory B cells early in the primary response. J Exp Med 209, 597&#x2013;606. 10.1084/jem.20111696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111696</ArticleId><ArticleId IdType="pmc">PMC3302224</ArticleId><ArticleId IdType="pubmed">22370719</ArticleId></ArticleIdList></Reference><Reference><Citation>Abzug MJ, Song LY, Fenton T, Nachman SA, Levin MJ, Rosenblatt HM, Pelton SI, Borkowsky W, Edwards KM, Peters J, and International Maternal Pediatric Adolescent ACTGPPT (2007). Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. Pediatrics 120, e1190&#x2013;1202. 10.1542/peds.2007-0729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-0729</ArticleId><ArticleId IdType="pubmed">17938165</ArticleId></ArticleIdList></Reference><Reference><Citation>Abzug MJ, Warshaw M, Rosenblatt HM, Levin MJ, Nachman SA, Pelton SI, Borkowsky W, Fenton T, International Maternal Pediatric Adolescent ACTGP, and Ps Protocol T (2009). Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis 200, 935&#x2013;946. 10.1086/605448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605448</ArticleId><ArticleId IdType="pmc">PMC2814776</ArticleId><ArticleId IdType="pubmed">19663708</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensieroso S, Cagigi A, Palma P, Nilsson A, Capponi C, Freda E, Bernardi S, Thorstensson R, Chiodi F, and Rossi P (2009). Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children. Proc Natl Acad Sci U S A 106, 7939&#x2013;7944. 10.1073/pnas.0901702106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0901702106</ArticleId><ArticleId IdType="pmc">PMC2683072</ArticleId><ArticleId IdType="pubmed">19416836</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensieroso S, Galli L, Nozza S, Ruffin N, Castagna A, Tambussi G, Hejdeman B, Misciagna D, Riva A, Malnati M, et al. (2013). B-cell subset alterations and correlated factors in HIV-1 infection. AIDS 27, 1209&#x2013;1217. 10.1097/QAD.0b013e32835edc47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0b013e32835edc47</ArticleId><ArticleId IdType="pubmed">23343911</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu HC, Wang R, Shinde PV, Walotka L, Huang A, Poschmann G, Huang J, Liu W, Stuhler K, Schaal H, et al. (2021). Slow viral propagation during initial phase of infection leads to viral persistence in mice. Commun Biol 4, 508. 10.1038/s42003-021-02028-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02028-x</ArticleId><ArticleId IdType="pmc">PMC8084999</ArticleId><ArticleId IdType="pubmed">33927339</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiale C, Greene TT, and Zuniga EI (2022). Interferon induction, evasion, and paradoxical roles during SARS-CoV-2 infection. Immunol Rev 309, 12&#x2013;24. 10.1111/imr.13113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.13113</ArticleId><ArticleId IdType="pmc">PMC9350402</ArticleId><ArticleId IdType="pubmed">35775361</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Fehr AR, Zheng J, Wohlford-Lenane C, Abrahante JE, Mack M, Sompallae R, McCray PB Jr., Meyerholz DK, and Perlman S (2019). IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest 129, 3625&#x2013;3639. 10.1172/JCI126363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI126363</ArticleId><ArticleId IdType="pmc">PMC6715373</ArticleId><ArticleId IdType="pubmed">31355779</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickerson BT, Westover JB, Jung KH, Komeno T, Furuta Y, and Gowen BB (2018). Effective Treatment of Experimental Lymphocytic Choriomeningitis Virus Infection: Consideration of Favipiravir for Use With Infected Organ Transplant Recipients. J Infect Dis 218, 522&#x2013;527. 10.1093/infdis/jiy159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiy159</ArticleId><ArticleId IdType="pmc">PMC6047442</ArticleId><ArticleId IdType="pubmed">29762684</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata S, Mikami Y, Sun HW, Brooks SR, Jankovic D, Hirahara K, Onodera A, Shih HY, Kawabe T, Jiang K, et al. (2017). The Transcription Factor T-bet Limits Amplification of Type I IFN Transcriptome and Circuitry in T Helper 1 Cells. Immunity 46, 983&#x2013;991 e984. 10.1016/j.immuni.2017.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.05.005</ArticleId><ArticleId IdType="pmc">PMC5523825</ArticleId><ArticleId IdType="pubmed">28623086</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinnakasu R, Inoue T, Kometani K, Moriyama S, Adachi Y, Nakayama M, Takahashi Y, Fukuyama H, Okada T, and Kurosaki T (2016). Regulated selection of germinal-center cells into the memory B cell compartment. Nat Immunol 17, 861&#x2013;869. 10.1038/ni.3460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3460</ArticleId><ArticleId IdType="pubmed">27158841</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciaranghella G, Tong N, Mahan AE, Suscovich TJ, and Alter G (2013). Decoupling activation and exhaustion of B cells in spontaneous controllers of HIV infection. AIDS 27, 175&#x2013;180. 10.1097/QAD.0b013e32835bd1f0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QAD.0b013e32835bd1f0</ArticleId><ArticleId IdType="pmc">PMC3729211</ArticleId><ArticleId IdType="pubmed">23135171</ArticleId></ArticleIdList></Reference><Reference><Citation>Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, Krishnan SR, Planta MA, Turney JF, Justement JS, et al. (2004). Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.[erratum appears in J Exp Med. 2004 Oct 4;200(7): following 946][republished from J Exp Med. 2004 Sep 6;200(5):587&#x2013;99;. Journal of Experimental Medicine 200, 587&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2262955</ArticleId><ArticleId IdType="pubmed">15353552</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Zhang Q, Hui H, Agrawal K, Karris MAY, and Rana TM (2020). An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics. Emerg Microbes Infect 9, 2333&#x2013;2347. 10.1080/22221751.2020.1826361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1826361</ArticleId><ArticleId IdType="pmc">PMC7646563</ArticleId><ArticleId IdType="pubmed">32954948</ArticleId></ArticleIdList></Reference><Reference><Citation>Amrute JM, Perry AM, Anand G, Cruchaga C, Hock KG, Farnsworth CW, Randolph GJ, Lavine KJ, and Steed AL (2022). Cell specific peripheral immune responses predict survival in critical COVID-19 patients. Nat Commun 13, 882. 10.1038/s41467-022-28505-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28505-3</ArticleId><ArticleId IdType="pmc">PMC8847593</ArticleId><ArticleId IdType="pubmed">35169146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, Yang P, Zhao Y, Zhuang Z, Wang Z, Song R, Zhang J, Liu C, Gao Q, Xu Q, et al. (2020). Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients. Immunity 53, 685&#x2013;696 e683. 10.1016/j.immuni.2020.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.07.009</ArticleId><ArticleId IdType="pmc">PMC7368915</ArticleId><ArticleId IdType="pubmed">32783921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk AJ, Rustagi A, Zhao NQ, Roque J, Martinez-Colon GJ, McKechnie JL, Ivison GT, Ranganath T, Vergara R, Hollis T, et al. (2020). A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med 26, 1070&#x2013;1076. 10.1038/s41591-020-0944-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0944-y</ArticleId><ArticleId IdType="pmc">PMC7382903</ArticleId><ArticleId IdType="pubmed">32514174</ArticleId></ArticleIdList></Reference><Reference><Citation>Knox JJ, Buggert M, Kardava L, Seaton KE, Eller MA, Canaday DH, Robb ML, Ostrowski MA, Deeks SG, Slifka MK, et al. (2017). T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 response. JCI Insight 2. 10.1172/jci.insight.92943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.92943</ArticleId><ArticleId IdType="pmc">PMC5396521</ArticleId><ArticleId IdType="pubmed">28422752</ArticleId></ArticleIdList></Reference><Reference><Citation>Muellenbeck MF, Ueberheide B, Amulic B, Epp A, Fenyo D, Busse CE, Esen M, Theisen M, Mordmuller B, and Wardemann H (2013). Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. J Exp Med 210, 389&#x2013;399. 10.1084/jem.20121970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20121970</ArticleId><ArticleId IdType="pmc">PMC3570107</ArticleId><ArticleId IdType="pubmed">23319701</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, Rubtsov AV, Cancro MP, and Marrack P (2015). Age-Associated B Cells: A T-bet-Dependent Effector with Roles in Protective and Pathogenic Immunity. J Immunol 195, 1933&#x2013;1937. 10.4049/jimmunol.1501209.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501209</ArticleId><ArticleId IdType="pmc">PMC4548292</ArticleId><ArticleId IdType="pubmed">26297793</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone SL, Peel JN, Scharer CD, Risley CA, Chisolm DA, Schultz MD, Yu B, Ballesteros-Tato A, Wojciechowski W, Mousseau B, et al. (2019). T-bet Transcription Factor Promotes Antibody-Secreting Cell Differentiation by Limiting the Inflammatory Effects of IFN-gamma on B Cells. Immunity 50, 1172&#x2013;1187 e1177. 10.1016/j.immuni.2019.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.04.004</ArticleId><ArticleId IdType="pmc">PMC6929688</ArticleId><ArticleId IdType="pubmed">31076359</ArticleId></ArticleIdList></Reference><Reference><Citation>Zumaquero E, Stone SL, Scharer CD, Jenks SA, Nellore A, Mousseau B, Rosal-Vela A, Botta D, Bradley JE, Wojciechowski W, et al. (2019). IFNgamma induces epigenetic programming of human T-bet(hi) B cells and promotes TLR7/8 and IL-21 induced differentiation. eLife 8. 10.7554/eLife.41641.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.41641</ArticleId><ArticleId IdType="pmc">PMC6544433</ArticleId><ArticleId IdType="pubmed">31090539</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsov AV, Rubtsova K, Fischer A, Meehan RT, Gillis JZ, Kappler JW, and Marrack P (2011). Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity. Blood 118, 1305&#x2013;1315. 10.1182/blood-2011-01-331462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-01-331462</ArticleId><ArticleId IdType="pmc">PMC3152497</ArticleId><ArticleId IdType="pubmed">21543762</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett BE, Staupe RP, Odorizzi PM, Palko O, Tomov VT, Mahan AE, Gunn B, Chen D, Paley MA, Alter G, et al. (2016). Cutting edge: B cell-intrinsic T-bet expression is required to control chronic viral infection. The Journal of Immunology 197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4975981</ArticleId><ArticleId IdType="pubmed">27430722</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, Rubtsov AV, van Dyk LF, Kappler JW, and Marrack P (2013). T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance. Proc Natl Acad Sci U S A 110, E3216&#x2013;3224. 10.1073/pnas.1312348110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312348110</ArticleId><ArticleId IdType="pmc">PMC3752276</ArticleId><ArticleId IdType="pubmed">23922396</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubtsova K, Rubtsov AV, Thurman JM, Mennona JM, Kappler JW, and Marrack P (2017). B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest. 10.1172/jci91250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci91250</ArticleId><ArticleId IdType="pmc">PMC5373868</ArticleId><ArticleId IdType="pubmed">28240602</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehar-Belaid D, Hong S, Marches R, Chen G, Bolisetty M, Baisch J, Walters L, Punaro M, Rossi RJ, Chung CH, et al. (2020). Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol 21, 1094&#x2013;1106. 10.1038/s41590-020-0743-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0743-0</ArticleId><ArticleId IdType="pmc">PMC7442743</ArticleId><ArticleId IdType="pubmed">32747814</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes RA, Batugedara G, Dutta P, Reers AB, Garza R, Ssewanyana I, Feeney ME, Greenhouse B, Bol S, Ay F, and Bunnik EM (2022). Single-cell sequencing identifies novel atypical B cell subsets with distinct effector functions. bioRxiv doi: 10.1101/2022.09.28.509955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.28.509955</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler NG, Bosinger SE, Estes JD, Zhu RT, Tharp GK, Boritz E, Levin D, Wijeyesinghe S, Makamdop KN, del Prete GQ, et al. (2014). Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511, 601&#x2013;605. 10.1038/nature13554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13554</ArticleId><ArticleId IdType="pmc">PMC4418221</ArticleId><ArticleId IdType="pubmed">25043006</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, and Perlman S (2016). Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. Cell Host Microbe 19, 181&#x2013;193. 10.1016/j.chom.2016.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.01.007</ArticleId><ArticleId IdType="pmc">PMC4752723</ArticleId><ArticleId IdType="pubmed">26867177</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere JJ, Serafini RA, Pryce KD, Zazhytska M, Oishi K, Golynker I, Panis M, Zimering J, Horiuchi S, Hoagland DA, et al. (2022). SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med 14, eabq3059. 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, Walzer T, Francois B, and Seve P (2020). Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev 19, 102567. 10.1016/j.autrev.2020.102567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102567</ArticleId><ArticleId IdType="pmc">PMC7196557</ArticleId><ArticleId IdType="pubmed">32376392</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokal A, Bastard P, Chappert P, Barba-Spaeth G, Fourati S, Vanderberghe A, Lagouge-Roussey P, Meyts I, Gervais A, Bouvier-Alias M, et al. (2023). Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination. J Exp Med 220. 10.1084/jem.20220258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20220258</ArticleId><ArticleId IdType="pmc">PMC9814155</ArticleId><ArticleId IdType="pubmed">36342455</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova JL, and Abel L (2022). From rare disorders of immunity to common determinants of infection: Following the mechanistic thread. Cell 185, 3086&#x2013;3103. 10.1016/j.cell.2022.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.07.004</ArticleId><ArticleId IdType="pmc">PMC9386946</ArticleId><ArticleId IdType="pubmed">35985287</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, and Topol EJ (2023). Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol, 1&#x2013;14. 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Good-Jacobson KL, Chen Y, Voss AK, Smyth GK, Thomas T, and Tarlinton D (2014). Regulation of germinal center responses and B-cell memory by the chromatin modifier MOZ. Proc Natl Acad Sci U S A 111, 9585&#x2013;9590. 10.1073/pnas.1402485111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1402485111</ArticleId><ArticleId IdType="pmc">PMC4084455</ArticleId><ArticleId IdType="pubmed">24979783</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafavi S, Yoshida H, Moodley D, LeBoite H, Rothamel K, Raj T, Ye CJ, Chevrier N, Zhang SY, Feng T, et al. (2016). Parsing the Interferon Transcriptional Network and Its Disease Associations. Cell 164, 564&#x2013;578. 10.1016/j.cell.2015.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.032</ArticleId><ArticleId IdType="pmc">PMC4743492</ArticleId><ArticleId IdType="pubmed">26824662</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh RM, and Seedhom MO (2008). Lymphocytic choriomeningitis virus (LCMV): propagation, quantitation, and storage. Curr Protoc Microbiol Chapter 15, Unit 15A 11. 10.1002/9780471729259.mc15a01s8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9780471729259.mc15a01s8</ArticleId><ArticleId IdType="pmc">PMC3220596</ArticleId><ArticleId IdType="pubmed">18770534</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson SM, Khalil A, Uduman M, Hershberg U, Louzoun Y, Haberman AM, Kleinstein SH, and Shlomchik MJ (2009). Taking advantage: high-affinity B cells in the germinal center have lower death rates, but similar rates of division, compared to low-affinity cells. J Immunol 183, 7314&#x2013;7325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106706</ArticleId><ArticleId IdType="pubmed">19917681</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, Hao Y, Stoeckius M, Smibert P, and Satija R (2019). Comprehensive Integration of Single-Cell Data. Cell 177, 1888&#x2013;1902 e1821. 10.1016/j.cell.2019.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.031</ArticleId><ArticleId IdType="pmc">PMC6687398</ArticleId><ArticleId IdType="pubmed">31178118</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoeckius M, Hafemeister C, Stephenson W, Houck-Loomis B, Chattopadhyay PK, Swerdlow H, Satija R, and Smibert P (2017). Simultaneous epitope and transcriptome measurement in single cells. Nat Methods 14, 865&#x2013;868. 10.1038/nmeth.4380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4380</ArticleId><ArticleId IdType="pmc">PMC5669064</ArticleId><ArticleId IdType="pubmed">28759029</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoeckius M, Zheng S, Houck-Loomis B, Hao S, Yeung BZ, Mauck WM 3rd, Smibert P, and Satija R (2018). Cell Hashing with barcoded antibodies enables multiplexing and doublet detection for single cell genomics. Genome Biol 19, 224. 10.1186/s13059-018-1603-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-018-1603-1</ArticleId><ArticleId IdType="pmc">PMC6300015</ArticleId><ArticleId IdType="pubmed">30567574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer A, Green J, Pollard J Jr., and Tugendreich S (2014). Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523&#x2013;530. 10.1093/bioinformatics/btt703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt703</ArticleId><ArticleId IdType="pmc">PMC3928520</ArticleId><ArticleId IdType="pubmed">24336805</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, and Mesirov JP (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102, 15545&#x2013;15550. 10.1073/pnas.0506580102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506580102</ArticleId><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, and Tamayo P (2015). The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst 1, 417&#x2013;425. 10.1016/j.cels.2015.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2015.12.004</ArticleId><ArticleId IdType="pmc">PMC4707969</ArticleId><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>RCoreTeam. (2022). R: A language and environment for statistical computing. . R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/.</Citation></Reference><Reference><Citation>Wickham H, Averick M, Bryan J, Chang W, D&#x2019;Agostino McGowan L, Fran&#xe7;ois R, Grolemund G, Hayes A, Henry L, Hester J, et al. (2019). Welcome to the Tidyverse. The Journal of Open Source Software
https://joss.theoj.org/papers/10.21105/joss.01686.</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.01686</ArticleId></ArticleIdList></Reference><Reference><Citation>RStudioTeam. (2022). RStudio: Integrated Development Environment for R. Boston, MA. http://www.rstudio.com/.</Citation></Reference><Reference><Citation>Xiao N (2021). ggsci: Scientific Journal and Sci-Fi Themed Color Palettes for &#x2018;ggplot2&#x2019;. https://nanx.me/ggsci/, https://github.com/nanxstats/ggsci.</Citation></Reference><Reference><Citation>Kassambara A (2020). _ggpubr: &#x2018;ggplot2&#x2019; Based Publication Ready Plots_. R package version 0.4.0
https://CRAN.R-project.org/package=ggpubr.</Citation></Reference><Reference><Citation>Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, et al. (2021). Integrated analysis of multimodal single-cell data. Cell 184, 3573&#x2013;3587 e3529. 10.1016/j.cell.2021.04.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.04.048</ArticleId><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart T, Srivastava A, Madad S, Lareau CA, and Satija R (2021). Single-cell chromatin state analysis with Signac. Nat Methods 18, 1333&#x2013;1341. 10.1038/s41592-021-01282-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01282-5</ArticleId><ArticleId IdType="pmc">PMC9255697</ArticleId><ArticleId IdType="pubmed">34725479</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang LG, and He QY (2015). ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382&#x2013;2383. 10.1093/bioinformatics/btv145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv145</ArticleId><ArticleId IdType="pubmed">25765347</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornes O, Castro-Mondragon JA, Khan A, van der Lee R, Zhang X, Richmond PA, Modi BP, Correard S, Gheorghe M, Baranasic D, et al. (2020). JASPAR 2020: update of the open-access database of transcription factor binding profiles. Nucleic Acids Res 48, D87&#x2013;D92. 10.1093/nar/gkz1001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz1001</ArticleId><ArticleId IdType="pmc">PMC7145627</ArticleId><ArticleId IdType="pubmed">31701148</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharer CD, Blalock EL, Barwick BG, Haines RR, Wei C, Sanz I, and Boss JM (2016). ATAC-seq on biobanked specimens defines a unique chromatin accessibility structure in naive SLE B cells. Sci Rep 6, 27030. 10.1038/srep27030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27030</ArticleId><ArticleId IdType="pmc">PMC4888756</ArticleId><ArticleId IdType="pubmed">27249108</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>